AVITA Medical (AVHHL) Current Deferred Revenue (2022 - 2026)

AVITA Medical (AVHHL) has reported Current Deferred Revenue for 5 consecutive years, with $306000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Deferred Revenue fell 10.0% year-over-year to $306000.0; the trailing twelve-month figure through Jun 2026 stood at $306000.0 (down 10.0% YoY), and the FY2025 full-year result was $323000.0, down 9.52% from the prior year.
• Current Deferred Revenue retreated to $306000.0 in Q2 2026 per AVHHL's latest filing, from $323000.0 in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $698000.0 in Q4 2022 and bottomed at $205000.0 in Q2 2024.
• Historically, Current Deferred Revenue has averaged $406285.7 across 5 years, with a median of $361000.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue tumbled 63.2% in 2024, then jumped 65.85% in 2025.
• Over 5 years, Current Deferred Revenue stood at $698000.0 in 2022, then tumbled by 44.13% to $390000.0 in 2023, then fell by 8.46% to $357000.0 in 2024, then decreased by 9.52% to $323000.0 in 2025, then dropped by 5.26% to $306000.0 in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $306000.0, $323000.0, and $331000.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.